Rhophylac 300 Anti-D is used to prevent the formation of antibodies against the Rh factor in the blood of women, for prophylaxis during pregnancy or after delivery in cases of Rh-incompatible pregnancies.
Rhophylac anti d injection is used to prevent the formation of antibodies against the Rh factor in the blood in cases of:
Pregnancy and obstetric conditions in non-sensitized Rh-negative women with an Rh-incompatible pregnancy (Rh-positive fetus). This includes routine antepartum Rh prophylaxis, as well as prophylaxis after delivery, in case of obstetric complications, or when invasive procedures are required.
Incompatible blood transfusions in Rh-negative individuals who receive blood components containing Rh-positive red blood cells.
Immune Thrombocytopenic Purpura (ITP): Rhophylac injections are also used to raise platelet counts in Rh-positive, non-splenectomized adults with chronic ITP.
Route: Intravenous (IV) or intramuscular (IM).
Routine antepartum prophylaxis: A single dose of 300 mcg at 28–30 weeks of pregnancy.
Postpartum prophylaxis: A single dose of 300 mcg within 72 hours after delivery.
Obstetric complications or invasive procedures: 300 mcg within 72 hours of the complication or intervention.
20 mcg per 2 mL of Rh-positive whole blood transfused, or per 1 mL of Rh-positive red blood cells.
50 mcg per kg of body weight, administered intravenously at a rate of 2 mL every 15–60 seconds.
Rhophylac 300 may cause some side effects, such as:
Nausea
Dizziness
Headache
Pain at the injection site
Fever
Chills
Hemolysis
Rhophylac injection should not be used in cases of:
Hypersensitivity to its components.
Anemia in patients with Immune Thrombocytopenic Purpura (ITP).
Keep out of reach of children.
Store at a temperature between 2–8 °C.
Do not freeze.
Keep in the original package, protected from light.
Do not store at room temperature, as the product contains no preservatives.